Questions about Quality Control? Ask our Expert Panel

Dr. Baumann is Co-Director of the Central Clinical Laboratory and Director of Central Processing at the Mayo Clinic in Rochester, MN. Dr. Baumann received her PhD in Biochemistry from the University of Wisconsin-Madison. She then completed a Clinical Chemistry Fellowship at Washington University School of Medicine in St. Louis and obtained board certification in clinical chemistry (ABCC). Her specific area of interest includes improving quality in the automated clinical laboratory. Dr. Baumann was the faculty chair for the AACC Certificate Program on Patient Safety Essentials for Laboratory Professionals.  She served on the CLSI Document Development Committee on Statistical Quality Control (C24) and was a faculty contributor to the AACC Certificate program on Quality Control in the Clinical Laboratory. Dr. Baumann is committed to education and teaching.  She currently is the program director of the Mayo Clinic Clinical Chemistry Fellowship Program.

Dr. Grenache is the chief scientific officer for TriCore Reference Laboratories in Albuquerque, New Mexico. In that role, he leads the TriCore Research Institute and works cooperatively to develop and implement TriCore’s scientific research strategy. He is also the medical director of the chemistry, immunology, and esoteric analytic chemistry labs, a clinical professor of pathology at the University of New Mexico, and president of the American Association for Clinical Chemistry. He is a diplomate of the American Board of Clinical Chemistry and a Fellow in the AACC Academy. His research interests are centered on leveraging longitudinal laboratory data to gain insights into population health and the diagnostic tests used to manage the pregnant patient.

Dr. Cervinski is the Director of Clinical Chemistry and Point-of-Care at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, and Associate Professor of Pathology and Laboratory Medicine at the Geisel School of Medicine at Dartmouth, in Hanover, New Hampshire. During Dr. Cervinski’s time at DHMC, the laboratory volume in chemistry has more than quadrupled as the hospital has affiliated with numerous critical access hospitals and outpatient clinics. He developed a clinical chemistry fellowship program that attained ComACC accreditation in 2015, and has trained four fellows to date, with two more in training. He is actively involved in the education of pathology residents and has served on the departmental Clinical Competency Committee for the past four years, and recently completed his first year as the Chair of the committee. Additionally, Dr. Cervinski developed DHMC’s moving averages program that detects shifts in assay performance long before the next scheduled quality control event.

Dr. Straseski is an Associate Professor of Pathology at the University of Utah School of Medicine. She is the section chief of clinical chemistry and medical director of endocrinology and automated core laboratories at ARUP Laboratories, a national reference laboratory in Salt Lake City, Utah.  She is board certified in clinical chemistry by the American Board of Clinical Chemistry and is a fellow of the AACC Academy. Dr. Straseski received her Ph.D. in pathology and laboratory medicine from the University of Wisconsin-Madison and completed a postdoctoral fellowship in clinical chemistry at the Johns Hopkins Medical Institutions in Baltimore, Maryland.  She is an active member of and holds leadership positions within the American Association for Clinical Chemistry and the American Society for Clinical Pathology.